Delivery Order SPE2DR25D1002-SPE2DR26FGN3G
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (via its parent company Cencora, Inc.) on January 9, 2026, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $11,167.12 and an ultimate completion date of January 12, 2026. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The pharmaceutical distributor will perform this work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,094.04 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency awarded a $2,277.36 delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 22, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is scheduled for completion by January 23, 2026. The work will be performed at Amerisourcebergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $2,341.44 and ultimate completion date of November 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The place of performance is listed as the contractor's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack units) with a ceiling value of $4,677.22. This is a firm fixed-price delivery order with an ultimate completion date of November 13, 2025, and represents a non-competitive set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,141.36 to AmerisourceBergen Drug Corp on January 15, 2026, for the procurement of Epinephrine 0.3 mg auto-injector two-packs. The contract is a firm fixed-price delivery order with an ultimate completion date of January 16, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not issued under any set-aside designation, indicating the contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Epinephrine 0.3 mg auto-injectors (2-pack) with a ceiling value of $1,162.86 and a firm fixed-price structure. This order will be completed by January 13, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The award was made on a fully competitive, non-set-aside basis, demonstrating the contractor's capability to meet federal procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of epinephrine 0.3 mg auto-injector (2-pack) with a ceiling value of $4,493.10. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by October 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs (two units per pack). This firm fixed price delivery order, valued at $4,035.65, represents a non-set-aside competitive award with an ultimate completion date of October 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGN3GDelivery Order
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) on January 28, 2026, for the supply of Epinephrine 0.3 mg auto-injector 2-packs at a ceiling value of $1,402.40. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of January 29, 2026. This delivery order is executed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. That comprehensive IDC serves as a global pharmaceutical support vehicle enabling Amerisourcebergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The company's federal contract portfolio demonstrates its critical role in supplying essential medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/27/26 |